These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30138539)

  • 21. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.
    Hashimoto Y; Matsubara T
    Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time.
    van Craenenbroeck AH; Bragfors-Helin AC; Qureshi AR; Lindholm B; Sjöberg B; Anderstam B; Heimburger O; Stenvinkel P; Bárány P
    Kidney Blood Press Res; 2017; 42(5):877-885. PubMed ID: 29161688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cost-effective method to get insight into the peritoneal dialysate effluent proteome.
    Araújo JE; Jorge S; Teixeira E Costa F; Ramos A; Lodeiro C; Santos HM; Capelo JL
    J Proteomics; 2016 Aug; 145():207-213. PubMed ID: 27216641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal dialysis: from bench to bedside and bedside to bench.
    Perl J; Bargman JM
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F999-F1004. PubMed ID: 27009336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dilution index as a candidate parameter reflecting dialysis dose in combined peritoneal dialysis and hemodialysis therapy].
    Maeda Y; Yamada T; Shiigai T
    Nihon Jinzo Gakkai Shi; 2004 Feb; 46(2):66-72. PubMed ID: 15058106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and pmma) during hemodialysis treatment using SELDI-TOF-MS.
    Ishikawa I; Chikazawa Y; Sato K; Nakagawa M; Imamura H; Hayama S; Yamaya H; Asaka M; Tomosugi N; Yokoyama H; Matsumoto K
    Am J Nephrol; 2006; 26(4):372-80. PubMed ID: 16873993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations.
    Pieroni L; Levi Mortera S; Greco V; Sirolli V; Ronci M; Felaco P; Fucci G; De Fulviis S; Massoud R; Condò S; Capria A; Di Daniele N; Bernardini S; Urbani A; Bonomini M
    Mol Biosyst; 2015 Jun; 11(6):1633-43. PubMed ID: 25845767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis.
    Ronci M; Leporini L; Felaco P; Sirolli V; Pieroni L; Greco V; Aceto A; Urbani A; Bonomini M
    Proteomics Clin Appl; 2018 Nov; 12(6):e1700140. PubMed ID: 29808585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD and HD in combination.
    Dell Aquila R; Ronco C
    Nefrologia; 2008; 28 Suppl 6():67-70. PubMed ID: 18957015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Combined Peritoneal Dialysis and Hemodialysis on Health-Related Quality of Life.
    Watanabe Y; Okada H
    Contrib Nephrol; 2018; 196():135-140. PubMed ID: 30041218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.
    Wong B; Ravani P; Oliver MJ; Holroyd-Leduc J; Venturato L; Garg AX; Quinn RR
    Am J Kidney Dis; 2018 Mar; 71(3):344-351. PubMed ID: 29174322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
    Vidal E; van Stralen KJ; Chesnaye NC; Bonthuis M; Holmberg C; Zurowska A; Trivelli A; Da Silva JEE; Herthelius M; Adams B; Bjerre A; Jankauskiene A; Miteva P; Emirova K; Bayazit AK; Mache CJ; Sánchez-Moreno A; Harambat J; Groothoff JW; Jager KJ; Schaefer F; Verrina E;
    Am J Kidney Dis; 2017 May; 69(5):617-625. PubMed ID: 27955924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conservative treatment, hemodialysis or peritoneal dialysis for elderly patients: The choice of treatment does not influence the survival].
    Rouveure AC; Bonnefoy M; Laville M
    Nephrol Ther; 2016 Feb; 12(1):32-7. PubMed ID: 26631312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Removal of Uremic Solutes by Peritoneal Dialysis.
    Meyer TW; Bargman JM
    J Am Soc Nephrol; 2023 Dec; 34(12):1919-1927. PubMed ID: 37553867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients.
    Zee J; Zhao J; Subramanian L; Perry E; Bryant N; McCall M; Restovic Y; Torres D; Robinson BM; Pisoni RL; Tentori F
    BMC Nephrol; 2018 Oct; 19(1):298. PubMed ID: 30373558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison Between Hemodialysis and Peritoneal Dialysis in the Risks for Disease Activity in LN-ESRD Patients: A Systematic Review and Meta-analysis.
    Gong Y; Zhao Y; Ran L; Liu Y
    Altern Ther Health Med; 2022 Sep; 28(6):144-149. PubMed ID: 35648699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Update on proteomic use in hemodialysis].
    Bonomini M; Sirolli V; Baroni S; Urbani A
    G Ital Nefrol; 2017 Aug; 34(4):28-34. PubMed ID: 28762680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis.
    Palmerini C; Piscitani L; Bologna G; Riganti C; Lanuti P; Mandatori D; Di Liberato L; Di Fulvio G; Sirolli V; Renda G; Pipino C; Marchisio M; Bonomini M; Pandolfi A; Di Pietro N
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics.
    Wen Q; Zhang L; Mao HP; Tang XQ; Rong R; Fan JJ; Yu XQ
    Biochem Biophys Res Commun; 2013 Aug; 438(3):473-8. PubMed ID: 23916703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.